Document Detail


A prospective, randomized, controlled study to compare two doses of recombinant human chorionic gonadotropin in serum and follicular fluid in woman with high body mass index.
MedLine Citation:
PMID:  19782346     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
This prospective, randomized, controlled study compares the efficiency of 250 microg or 500 microg of recombinant hCG in serum and follicular fluid (FF) levels and pregnancy rates (PR) in women with high body mass index (BMI) (>or=26 kg/m(2)) undergoing assisted reproduction treatment (ART). Treatment outcomes are similar between the two groups.
Authors:
Semra Kahraman; Guvenc Karlikaya; Mustecep Kavrut; Hale Karagozoglu
Related Documents :
22567496 - A case of torsion of gravid uterus caused by leiomyoma.
806946 - Mucocililary activity in the respiratory tract as influenced by prostaglandin e.
7775296 - Fluid changes during pregnancy: use of bioimpedance spectroscopy.
12225146 - Heat capacity of 3he in aerogel.
9166306 - The reliability of performing a screening cystometrogram using a fetal monitoring devic...
17233866 - The use of a perinatal internet consultation forum in israel.
Publication Detail:
Type:  Comparative Study; Journal Article; Randomized Controlled Trial     Date:  2009-09-26
Journal Detail:
Title:  Fertility and sterility     Volume:  93     ISSN:  1556-5653     ISO Abbreviation:  Fertil. Steril.     Publication Date:  2010 Apr 
Date Detail:
Created Date:  2010-03-30     Completed Date:  2010-04-16     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0372772     Medline TA:  Fertil Steril     Country:  United States    
Other Details:
Languages:  eng     Pagination:  2084-7     Citation Subset:  IM    
Copyright Information:
Copyright 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.
Affiliation:
Istanbul Memorial Hospital, Istanbul, Turkey. skahraman@superonline.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Body Mass Index*
Chorionic Gonadotropin / administration & dosage*,  adverse effects,  analysis
Dose-Response Relationship, Drug
Female
Follicular Fluid / chemistry,  drug effects*
Humans
Obesity / blood*,  metabolism
Oocyte Retrieval
Oocytes / drug effects,  metabolism
Overweight / blood*,  metabolism
Pregnancy
Pregnancy Rate
Recombinant Proteins / administration & dosage,  adverse effects
Reproductive Techniques, Assisted
Treatment Outcome
Chemical
Reg. No./Substance:
0/Chorionic Gonadotropin; 0/Recombinant Proteins

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Reduced Orbitofrontal and Parietal Gray Matter in Chronic Insomnia: A Voxel-Based Morphometric Study...
Next Document:  Vitrification of isolated human blastomeres.